Chromium is the sixth element seen on the earth. It is used in the production of stainless steel, painting, welding, metallurgy industry, and leather industry.\[[@ref1]\] Occupational exposure to Cr (VI) is found in nearly half a million industrial workers in the developing countries and several million worldwide.\[[@ref2]\] Hexavalent chromium, Cr (VI), has been identified as extremely toxic and carcinogenic.\[[@ref3]\] The major adverse effect of the chromium toxicity has been reported as nephrotoxicity.\[[@ref4]\] Some studies performed on mammalians showed that exposure to Cr (IV) is related with cancer progression.\[[@ref3][@ref5]\] *In vivo* and *in vitro* reactions mediated by Cr (VI) have shown that Cr (VI) may cause the activation of nuclear transcription factor-KB, single and double DNA chain fractionation, formation of 8-hydroxy-deoxyguanosine included cellular damage.\[[@ref6]\] The reduction of Cr (VI) by cellular reductants to its lower oxidation states, Cr (V), Cr (IV), and Cr (III), has been considered an important step in cellular mechanisms. Data show that these reactive chromium intermediates are capable of generating reactive oxygen species (ROS) that induce the oxidative stress.\[[@ref7]\] The increased ROS production has been suggested to be an important agent of cell death in different renal diseases and genotoxicity.\[[@ref6]\]

Caffeic acid phenethyl ester (CAPE), produced from the bee propolis, may protect organisms against oxidative stress-induced damage. A study has demonstrated the healing effects of CAPE in the treatment of oxidative stress.\[[@ref8]\] Melatonin (N-acetyl-5-methoxytryptamine) is a neurohormone which is secreted rhythmically and has physiological functions such as regulation of immune system and circadian rhythms.\[[@ref9]\] Recently, it has been shown that melatonin has an oxidative stress healing effect.\[[@ref10]\] It performs this activity by scavenging free radicals.

In light of the above data, this study was undertaken to assess possible protective effects of melatonin and CAPE on potassium dichromate (K~2~Cr~2~O~7~)-induced nephrotoxicity and genotoxicity.

Materials and Methods {#sec1-1}
=====================

Ethics {#sec2-1}
------

All experimental procedures were approved by the Committee for Animal Experiments and the Ethics Committee of Istanbul University (approval number: 2011/89).

Wistar albino rats weighing about 250--300 g housed under 12 h light/12 h dark, and fed standard diet and water. Rats were divided into five groups (*n* = 8/group). (1) Control received single-dose isotonic saline intraperitonally (i.p.), (2) K~2~Cr~2~O~7~, rats received one dose injection of K~2~Cr~2~O~7,~15 mg/kg i.p., (3) K~2~Cr~2~O~7~ + melatonin, which was given single-dose K~2~Cr~2~O~7~i.p. and 4 mg/kg melatonin injected per day for 2 days, (4) K~2~Cr~2~O~7~ + CAPE, which were given single dose K~2~Cr~2~O~7~i.p. and 10 μmol/kg CAPE injected per day i.p. for 2 days, (5) K~2~Cr~2~O~7~ + melatonin + CAPE given i.p. single dose per day for 2 days. Rats were sacrified 24 h later.

Sample Collection and Biochemical Assays {#sec2-2}
----------------------------------------

After scarification of rats under ketamine (100 mg/kg) and xylazine (10 mg/kg) anesthesia, both kidneys were taken, and one of them was fixed in 10% formalin for further histopathological assays. The other kidney was stored at −80°C for biochemical analysis. Kidney samples were then thawed and homogenized in 0.15 M KCI (10 w/v) and centrifuged at 10.000 g for 45 min (+4°C) for the biochemical analysis. Blood samples were taken before scarification and used for both genotoxicity and ELISA assays.

Comet Assay for DNA Damage Detection {#sec2-3}
------------------------------------

Genotoxic effects were analyzed by electrophoresis using alkaline single cell gel electrophoresis (Comet assay).\[[@ref11]\] This method depends on the detection of single chain fractionation, double chain fractionation, and miss nucleotide excision repair of DNA damage in a single cell and distribution in the cell population. Damaged DNA is shown as a tail in the gel electrophoresis.

Histopathological Examination of the Kidney {#sec2-4}
-------------------------------------------

The kidney tissues were removed and fixed in 10% neutral phosphate-buffered formaldehyde, dehydrated with graded alcohol series, cleared with toluene and embedded into paraffin. These kidney tissues were cut into five micrometer thick sections and were stained with hematoxylin and eosin. Slides were examined under the light microscope at ×400 (LEICA DM2500). A semi-quantitative evaluation of kidney tissues was accomplished by scoring the degree of severity according to previously published criteria.\[[@ref12]\] For each renal section, the whole slide was examined for tubular necrosis, tubular vacuolization, and hyaline casts (hcs). In brief, minimum of fifty proximal tubules associated with fifty glomeruli were examined for each slide and an average score was obtained. Slides were examined and assigned for severity of changes using scores on a scale of none (0), mild (1), moderate (2), and severe damage (3), in which (0) denotes no change; grade (1) changes affecting \<25% of tubular damage (mild); grade (2) changes affecting 25--50% of the tubules (moderate); grade (3) changes affecting \>50% of the tubules (severe).\[[@ref13]\]

Determination of Glutathione Reductase, Superoxide Dismutase, Catalase, Glutathione, Glutathione S-transferase and Malondialdehyde Levels {#sec2-5}
-----------------------------------------------------------------------------------------------------------------------------------------

Supernatant was used for glutathione (GSH), catalase (CAT), superoxide dismutase (SOD), glutathione reductase (GR), Glutathione S-transferase (GST), and malondialdehyde (MDA) experiments. GSH amounts were determined according to the method of Beutler *et al*.\[[@ref14]\] CAT activity has been determined by measuring the decomposition of hydrogen peroxide.\[[@ref15]\] Total SOD activity measured inhibition of nitro blue tetrazolium reduction by xantine oxidase used as a superoxide generator.\[[@ref16]\] Color concentration was measured at 560 nm. GST levels were evaluated by the method of Habig *et al*.\[[@ref17]\] GR levels were measured by described elsewhere.\[[@ref18]\] GR assay depends on reduction of oxidized GSSG by NADPH GR. MDA levels were determined by measurement of thiobarbituric acid (TBA) reactivity.\[[@ref19]\]

ELISA Assay {#sec2-6}
-----------

Serum melatonin levels were measured with ELISA method\[[@ref20]\] (Cusabio Biotech, Wuhen, China) according to the manufacturer\'s instructions.

Results {#sec1-2}
=======

Comet Assay Scores {#sec2-7}
------------------

The K~2~Cr~2~O~7~ group of lymphocytes showed 2^nd^ and 3^rd^ degree damage as compared to control group. When the K~2~Cr~2~O~7~ group was compared with the K~2~Cr~2~O~7~ + melatonin group and K~2~Cr~2~O~7~ + CAPE group, it was found that DNA breaks were significantly decreased (*P* \< 0.05). When the K~2~Cr~2~O~7~ group was compared with the K~2~Cr~2~O~7~ + CAPE group, tail factor did not change \[[Figure 1](#F1){ref-type="fig"}\].

![Semi-quantitative analysis of renal injury in different treatment groupsComet assay. Control group (a). Potassium dichromate group (b). Melatonin-treated potassium dichromate group (c), caffeic acid phenethyl ester-treated potassium dichromate group (d), melatonin and caffeic acid phenethyl ester treated potassium dichromate group (e)](IJPharm-48-407-g001){#F1}

Blood Urea Nitrogen and Serum Creatinine Levels {#sec2-8}
-----------------------------------------------

Urea and serum creatinine (SCr) levels were 21.51 ± 1.43 mg/dl and 0.36 ± 0.02 mg/dl in the control group, 125 ± 4.09 mg/dl and 3.08 ± 0.10 mg/dl in K~2~Cr~2~O~7~ group and 103.02 ± 3.70 mg/dl and 0.72 ± 0.15 mg/dl in K~2~Cr~2~O~7~+ Melatonin + CAPE group, respectively (*P* \< 0.001).

Serum Melatonin Levels {#sec2-9}
----------------------

Serum melatonin levels for different treatment groups are shown in [Table 1](#T1){ref-type="table"}. Serum levels of melatonin in K~2~Cr~2~O~7~+ CAPE-treated group were significantly higher when all groups were compared with each other (*P* = 0.003) \[[Table 1](#T1){ref-type="table"}\].

###### 

Effect of different treatments on serum melatonin levels in rats

![](IJPharm-48-407-g002)

Histopathological Results {#sec2-10}
-------------------------

The kidney sections from the control group showed normal structural integrity \[[Figure 2a](#F2){ref-type="fig"}\]. Necrosis in the proximal and distal tubules and hcs were observed in the rats given K~2~Cr~2~O~7~ \[[Figure 2b](#F2){ref-type="fig"}\]. Although the administration of melatonin reduced histopathological damage in the nephrotoxicity caused by potassium dichromate, histological damage was not completely recovered as compared with controls. In the renal cortex, tubular necrosis and hc depositions were decreased \[[Figure 2c](#F2){ref-type="fig"}\]. In the CAPE group, renal damage was significantly decreased as compared with K~2~Cr~2~O~7~ group \[[Figure 2d](#F2){ref-type="fig"}\]. The CAPE and melatonin coadministered group, showed better histopathologic findings compared with all three treatment groups \[[Figure 2e](#F2){ref-type="fig"} and [Table 2](#T2){ref-type="table"}\].

![H and E, staining of kidney sections. In the control group, normal histological appearance of renal cortex, glomerulus, and tubular epithelial cells (a). In the potassium dichromate, group glomeruli appear normal, damage to tubular epithelial cells (→) and presence of hyaline casts in the tubular lumen (b). In the melatonin-treated potassium dichromate group (c) and caffeic acid phenethyl ester-treated potassium dichromate (d), the presence of hyaline casts in tubular lumen. Glomeruli appear normal. Melatonin and caffeic acid phenethyl ester treated potassium dichromate group, the generally intact tubular epithelial cells and a cast free tubular lumen. Glomeruli appear normal (e) (p: Proximal tubule, d: Distal tubule, g: Glomeruli, hc: Hyaline cast \[Bar 20 μm\])](IJPharm-48-407-g003){#F2}
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Semi-quantitative analysis of renal injury in different treatment groups
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Glutathione Reductase, Superoxide Dismutase, Catalase, Glutathione, Glutathione S-transferase, and Malondialdehyde Levels {#sec2-11}
-------------------------------------------------------------------------------------------------------------------------

GR levels were decreased by K~2~Cr~2~O~7~ administration when compared with control group as shown in [Table 3](#T3){ref-type="table"} (*P* \< 0.05). This decrease is tend to be slightly increased by melatonin and CAPE administration together. However, this increase could not reach to statistically significant levels. SOD, CAT, GSH, GST, and MDA levels have not changed in K~2~Cr~2~O~7~-treated rats when compared with controls, but CAT activities were increased by administration of CAPE and CAPE + melatonin (*P* \< 0.05), \[[Table 3](#T3){ref-type="table"}\].

###### 

Effects of melatonin and caffeic acid phenethyl ester on rat renal injury parameters
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Discussion {#sec1-3}
==========

The K~2~Cr~2~O~7~ is widely used in industry and exposure to K~2~Cr~2~O~7~ has been involved in the pathophysiology of cytotoxicity, genotoxicity, neurotoxicity, immunotoxicity, and nephrotoxicity. Chromium exposure has been reported to cause acute renal failure in mammals. It was also reported that chronic exposure to chromium, caused damage in renal proximal tubular epithelial cells, and this leads to proximal tubules failure which was also reported to cause lipid peroxidation.\[[@ref3][@ref8]\] In our study, we observed that there was severe histopathological changes such as necrosis, vacuolation and hcs in single dose K~2~Cr~2~O~7~-treated group of rat kidney tissue proximal tubules. The work carried out to date of antioxidants consisting of chromium has been reported to show a protective effect on oxidative damage and nephrotoxicity. Therefore, it is considered antioxidants may have a protective effect in the treatment of chromium exposure.

It has been shown that incubation of primary cultures of rat hepatocytes with K~2~Cr~2~O~7~ plus the pineal hormone melatonin resulted a decrease in DNA single-strand breaks caused by K~2~Cr~2~O~7~, suppressed dichromate-induced cytotoxicity, lipid peroxidation, and the inhibition of CAT activity.\[[@ref4][@ref5]\] The CAPE has many biological functions including anti-inflammatory, antiviral, immunomodulatory, antiangiogenic, anti-invasive, antimetastatic, carcinostatic, and antioxidant.\[[@ref8]\]

To the best of our knowledge, there is no study in the literature exploring short-term protective effects of both melatonin and CAPE together in K~2~Cr~2~O~7~ induced nephrotoxicity in rats. However, it has been determined that melatonin has a protective effect on methotrexate, FK506, gentamicin, cisplatin, uranium, acetaminophen, and radiation-induced renal damage and CAPE has a protective effect on acetylsalicylic acid, gentamicin, cyclosporin A, methotrexate, and cadmium-induced nephrotoxicity in rats in some studies.\[[@ref21][@ref22]\] This in turn suggests that melatonin and CAPE may be effective in improving the K~2~Cr~2~O~7~ induced nephrotoxicity and has helped us to establish our hypothesis.

A study, reported that melatonin reduced the level of CAT enzyme inhibition, however, has no alteration in cellular GSH, GR, GPx, and SOD.\[[@ref4]\] In another study, they investigated the effects of the K~2~Cr~2~O~7~ induced nephrotoxicity on antioxidant enzymes, and they reported that GR and CAT enzyme levels were decreased, however, SOD enzyme levels were not significantly changed in K~2~Cr~2~O~7~ induced rats.\[[@ref5]\] In our study, we detected that K~2~Cr~2~O~7~ treatment did not change CAT enzyme activity, however, the treatment of both melatonin and CAPE have significantly augmented CAT enzyme activity. The augmentation in CAT activity may reduce the free radicals formed by K~2~Cr~2~O~7~ and may ameliorate nephrotoxicity suggesting the synergistic roles of melatonin and CAPE. Our results are consistent with Soudani *et al*.\'s and Susa *et al*.\'s studies in which increased activity of CAT enzyme with the antioxidant applications were observed.\[[@ref4][@ref5][@ref23]\] A significant difference was observed between all groups when compared with one-way ANOVA, however, when the two groups were compared with each other protective applications did not have a significant role. This result is consistent with Soudani *et al*.\'s findings in which they observed increased MDA levels with antioxidant treatment.\[[@ref23]\] Pedraza-Chaverri *et al*. reported that GR levels were decreased with K~2~Cr~2~O~7~ treatment, and they observed no significant effect of the antioxidant treatment on enzyme levels.\[[@ref5]\] When all the groups were examined, there was no significant difference between the GSH levels and the GST, and SOD enzyme activities. Our results were parallel with the findings of Pedraza-Chaverri *et al*. and Susa *et al*., however, were not consistent with Soudani *et al*.\[[@ref4][@ref5]\]

Besides this, in our study, melatonin and CAPE together, inhibited the increase in urea and SCr levels induced by K~2~Cr~2~O~7~. Our results were consistent with the previously reported study in which melatonin significantly reduced methotrexate-induced elevation in plasma creatinine in rats.\[[@ref21]\]

There are some reports investigating the genotoxicity of K~2~Cr~2~O~7~.\[[@ref24][@ref25][@ref26]\] In a study which is performed in *Cyprinus carpio*, it has been noted that genotoxicity induced by K~2~Cr~2~O~7~ indicated a concentration-dependent increase in DNA damage.\[[@ref24]\] Kaya *et al*. reported that ascorbic acid was effective in reducing the genotoxicity of K~2~Cr~2~O~7~ according to the control level in their study.\[[@ref25]\] Fahmy *et al*. showed the genotoxic effect of K~2~Cr~2~O~7~ in mice. The results of the same study also confirmed the protective role of thiola and soybean seeds against the genotoxicity of K~2~Cr~2~O~7~.\[[@ref26]\] CAPE and melatonin are known to have oxidative stress healing features.\[[@ref12][@ref14]\] The cause of the genotoxicity may be oxidative stress,\[[@ref25]\] and these compounds may have healing effects.

In our study, we observed that CAPE-treated group has lower tail factors (%) than that of K~2~Cr~2~O~7~ group, however, our results were not statistically significant. Besides, in the melatonin-treated group, we observed a repair in the DNA damage and a statistically significant reduction in the % of the tail factor. Our study was in parallel with Susa *et al*.\'s study.\[[@ref4]\]

In standard drug therapy, management is focused on life-threatening features. Fluid balance, treatment of acidosis, using diuretics, dopamine, and coping with obstruction are the issues in the further management. Furthermore, standard drug therapy may ameliorate increasing SCr levels however renal failure may remain in acute chromium poisoning. That is why novel therapies are preferred in addition to standard drug therapy. These therapies involve more specific experimental treatments including some oxygen free radical scavengers designed to reduce renal damage. In our study, melatonin and CAPE-treated groups exhibited lower renal damage, and melatonin and CAPE may serve as free radical scavengers in conjunction with each other.

We also have found that serum melatonin levels increased significantly in the group treated with CAPE. These results may show that CAPE may contribute to endogenous melatonin synthesis and may increase the levels of this molecule. On the other hand, our histopathological results showed that the improvement of the histopathological changes in renal tubular epithelial cells was found to be more prominent in melatonin + CAPE group than that of K~2~Cr~2~O~7~. Thus, we suggest that treatment of melatonin together with CAPE may have renoprotective effect against K~2~Cr~2~O~7~ nephrotoxicity. There are also some limitations in our study. Some of the antioxidant enzyme levels we studied, did not have a statistically significant increase since we examined the acute effects of K~2~Cr~2~O~7~ on nephrotoxicity. It is concluded that although melatonin + CAPE supplement has a very powerful nephroprotective effect, the amelioration of the antioxidant parameters take a long time to be significant enough. Long-term drug treatment may be more effective for this condition. Further studies may enlighten the synergistic effects of melatonin together with CAPE on the chronic effects of K~2~Cr~2~O~7~ nephrotoxicity.
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